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HYPOTHALAMIC AND PITUITARY CONTROL OF 
THYROID FUNCTION* 
PETER C. SCRIBA, M . D . t 
To remain wi th in reasonable limitations of 
space, this discussion o f the hypothalamic and 
pituitary control o f thyroid function is re-
stricted to selected aspects o f the problem. 
Reviews are available (1-3). The diagram o f the 
regulation o f the system (Figure 1) is a familiar 
one. It depicts schematically the hypothalamic 
area, where biosynthesis and release o f the 
hypophyseotropic hormone T R H take place. 
The synthetic tripeptide 1-pyro-glutamyl-
1-histidyl-l-prolinamide is identical w i t h nat-
ural thyrotropin-releasing hormone o f a large 
number o f species. T R H stimulates the release 
and the formation o f thyrotropin (TSH) in the 
thyrotrophs o f the anterior pituitary. TSH in 
turn stimulates the thyro id , so that appropriate 
levels o f the thyroid hormones thyroxine ( T 4 ) 
and tri iodothyronine ( T 3 ) are provided. A 
minute part o f the thyroid hormones circulates 
in free form. There is ample evidence that free 
T 4 and free T 3 are the direct effectors o f the 
system as far as biological effects and the 
negative feedback upon TSH secretion are 
concerned. It may be somewhat surprising that 
the other regulatory interrelations o f this 
system are still far from clear-cut. 
Looking at the role of catecholamines, we 
note that chronic administration of L-dopa 
reduces the TSH response to T R H stimulation 
(4). Rapoport and co-workers (5) observed a 
decrease in the elevated TSH levels o f hypo-
thyroid patients after acute administration o f 
L-dopa. So far, neuroendocrinologists have 
tended toward the interpretation that L-dopa 
acts by increasing the formation o f hypo-
thalamic dopamine. The findings just men-
*This work was supported by the Deutsche For-
schungsgemeinschaft (SFB 51). 
t Medical Clinic, University o f Munich, Munich, 
Germany. 
tioned might be better explained by a direct 
inhibitory effect o f L-dopa on the thyrotroph. 
However, there is yet another hypothesis: Noel 
and co-workers (6) have reported that the 
response of human pituitary prolactin to T R H 
is reduced after L-dopa. These authors explain 
their observation as a direct pituitary inhibi-
t ion, or alternatively as an L-dopa-stimulated 
secretion o f prolactin inhibiting factor (PIF) 
exceeding the effect of exogenous T R H . Like-
wise, a hypothalamic inhibitor o f pituitary TSH 
release has recently come into consideration 
through the observations of Bowers and co-
workers (7) . These authors confirmed that the 
synthetic tetradecapeptide GIF (growth hor-
mone inhibitor, also called somatostatin) in-
hibits the TSH response to T R H in vitro. The 
physiologic role o f a possible hypothalamic 
inhibitor o f TSH secretion remains unknown. 
From the clinician's standpoint it is desirable 
to have a function test which would stimulate 
the entire axis from the hypothalamus through 
the pituitary and thyroid (Figure 1), com-
parable to the insulin hypoglycemia test. Such a 
test does not exist. Cold exposure has been 
tried in this respect, since it increases TSH 
levels in rats and in infants and children (8, 9). 
However, no TSH rise could be detected in 
adult human subjects following short-term cool-
ing or surgical hypothermia (8, 9). 
I should like to discuss briefly the question 
o f the specificity o f TRH in releasing pituitary 
hormones. A n exception to its specificity is 
observed in some acromegalic patients who 
respond to T R H stimulation wi th an increase in 
GH levels (10). Moreover, as already men-
tioned, T R H stimulates prolactin secretion in 
addition to TSH secretion in humans. Follow-
ing the injection o f synthetic T R H in pharma-
cologic dosages, the prolactin levels o f females 
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F I G U R E 1. Schematic presentation of hypothalamic and pituitary control of 
thyroid function. 
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show a more pronounced rise than those o f 
males (77, 12). After T R H stimulation o f cows, 
Kelly and co-workers (13) observed an 11-fold 
increment in prolactin levels compared wi th a 
3-fold rise in TSH. In cows T R H has no effect 
on milk production or composition. However, 
our veterinarian colleagues in Munich (14) have 
reported that treatment o f heifers wi th T R H 
results in a stimulation of mammogenesis and 
lactogenesis, wi th milk yields subsequently in-
creased by some 50 per cent, whereas galac-
topoiesis in cows was not affected. 
From the effects o f these pharmacologic 
amounts o f T R H , conclusions as to the physi-
ologic regulation of thyroid function by the 
hypothalamus and pituitary (Figure 1) can be 
drawn only wi th extreme caution. In thyroid-
ectomized lambs both prolactin and TSH levels 
rise, presumably through increased secretion of 
endogenous T R H (75). Nursing increases pro-
lactin levels 10-fold in women without con-
comitant TSH rises (76). A t present it would 
appear that at least some physiologic stimuli 
affect TSH and prolactin secretion differently. 
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Our understanding o f the hypothalamic 
regulation o f the thyrotrophs can be expected 
to increase considerably as the result o f direct 
determinations of T R H levels in the circulation. 
Radioimmunoassay procedures for T R H have 
been reported by the groups o f Utiger (77, 18), 
Wilber (79) , Porter (20), and Reichlin (21). 
Unfortunately, T R H is very rapidly inactivated 
in vitro by serum (77); in addition, the half-life 
o f circulating T R H is very short and depends on 
the thyroidal status. Jackson and Reichlin (21) 
observed an increase in urinary T R H in rats 
following cold exposure, whereas Oliver and 
co-workers (20) could not detect T R H in 
peripheral plasma o f thyroidectomized rats 
w i t h an assay that showed detectable TRH 
levels in the peripheral and portal blood of 
normal rats. Thus, at present we cannot assess 
the importance under physiologic conditions, 
o f positive or negative feedback of thyroid 
hormones upon T R H secretion, nor do we 
know the significance o f negative feedback o f 
TSH levels upon T R H secretion. 
Let us now consider briefly the control of 
thyroid function in the absence o f endogenous 
T R H . In patients wi th hypothalamic disease, 
moderate hypothyroidism is usually observed, 
w i t h TSH low but by no means completely 
absent. T R H stimulation o f patients w i t h supra­
sellar disease and secondary hypothyroidism 
results in normal or supranormal TSH increases 
(Table 1). Surprisingly, we likewise observed a 
normal stimulation o f TSH secretion by T R H in 
most patients w i t h pituitary adenomas and 
secondary hypothyroidism (22). I n patients 
w i t h pituitary tumors i t would therefore appear 
that hypothalamic T R H production or T R H 
transport via the portal vessels o f the pituitary 
stalk is more susceptible to disturbance than 
the TSH-producing thyrotrophs in the anterior 
T A B L E 1. T S H response to a standard T R H stimulation test (200 μg i.v.) in disorders of the 
hypothalamus and the pituitary(22). 
S E R U M - T S H jiU/ml 
INCREMENT 30MIN A F T E R TRH (200jig) 
Ν 
NORMAL RANGE ( l o g ) 
2.73 - 23.6 j jU/ml 
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REPRESENT SURPRISING RESULTS. 
36 //. Hormone Production and Goitrogenesis Mechanism 
pituitary itself. The residual regulation of TSH 
secretion in rats w i th hypothalamic lesions, 
which would eliminate T R H , is slow in terms of 
TSH response to thyroidectomy and more 
sensitive to T 4 w i th respect to TSH suppression 
(23). 
As we all know, TSH stimulates the release 
and synthesis o f thyroid hormone, as well as 
thyroidal growth. To relate endemic goiter to 
the biochemical action o f TSH, one might recall 
the study o f Pisarev and co-workers (24), who 
were able to produce goiters in mice by chronic 
application o f cyclic AMP. I t may have more 
clinical relevance to remember the various 
causes o f thyroidal growth in the absence o f 
TSH. We have observed (Table 2) cases o f 
proven TSH deficiency w i t h either thyroidal 
growth or hyperthyroidism, or both (25). 
Along these lines, we should mention briefly 
the phenomenon of thyroidal autoregulation 
(26), which wi l l be dealt w i t h elsewhere at this 
meeting. O f interest, iodine depletion studies in 
rats (27) have shown an increased sensitivity o f 
the iodine-depleted gland to the goitrogenic 
effect o f TSH. 
I t is apparent, then, that despite significant 
advances in our knowledge o f the physiology 
and pathophysiology o f thyroid regulation by 
the hypothalamus and pituitary, there are still 
many open questions which must be answered 
through continued research. 
Certain diagnostic implications o f the thy­
roid-pituitary feedback have, in the view of 
T A B L E 2. Differential diagnosis of thyroid growth 
and/or thyrotoxicosis in the absence of T S H (25). 
# Thyroid Malignancy 
Primary or Secondary 
# Thyroiditis (Hashimoto) 
# Acromegaly (Visceromegaly) 
φ Graves Disease (LATS?) 
φ Autonomous Adenoma 
φ (Thyrotoxicosis factitia) 
many, led to major clinical progress. During the 
last two or three years, the radioimmunological 
determination o f TSH in serum and its stimula­
t ion w i th synthetic T R H have been broadly 
applied by many investigators. 
TSH-one o f the glycoproteohormones o f 
the anterior pi tui tary-was shown to consist o f 
two subunits (a and β) by Pierce and co­
workers (28). Recently, Shome and Parlow (29) 
announced the primary structure o f human 
P-TSH, which differs from bovine ß - T S H i n 12 
amino acids. Radioimmunoassays for the hor-
mone-specific 0-subunit w i l l probably soon be 
introduced into clinical endocrinology. 
The radioimmunoassay for TSH, though 
widely used, still presents some problems. 
Adams and co-workers (30) demonstrated lack 
o f identity for TSH levels below 5 μ υ / m l , when 
bioassay and radioimmunoassay were com­
pared. In addition, using gel chromatography, 
Dimond and Rosen (31) showed heterogeneity 
o f circulating TSH when compared wi th pi­
tuitary TSH. The use o f standards dissolved in 
hormone-free serum-as recommended, for 
example, by Patel and co-workers (32)-
corrects erroneously high TSH levels, which w i l l 
be found i f a tracer TSH of too high specific 
activity is used. As can be seen in Figure 2, 
tracer of a rather low specific activity wi l l give 
the correct recovery values for the TSH added. 
As for the sensitivity problem, various measures 
have been proposed, including incubation at 
room temperature, preincubation o f TSH anti­
body and cold hormone, low tracer concentra­
t ion , and use o f dilute antiserum (32-34). 
Despite these efforts, the basal TSH levels o f 
control groups are still found to vary from 
below the l imi t o f detection to 3 or 4 μ ϋ / m l . 
With this sensitivity, low normal and suppressed 
basal TSH levels may not be discerned. 
For diagnostic purposes, however, the ap­
parent lack of sensitivity can be readily over­
come by the introduction o f T R H stimulation 
tests. A standard T R H stimulation test is now 
performed by many groups, w i th rapid i.v. 
injection o f 200 μ% T R H and 0 and 30-minute 
sampling for TSH determination. This proce­
dure has resulted in a normal range-mean ± 2 
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F I G U R E 2. Effect of the specific activity of tracer 
TSH on the radioimmunoassay of T S H : Comparison 
of standards in serum and in buffer solution (33). 
RECOVERY 
[ u U TSH/ml] 
~~Π To Ts To £ 
Amount added 
[ pUTSH/ml] 
S D - o f the TSH increment ( Δ T S H 3 0 m i n ) of 2.7 to 23.6 μ ϋ / m l , assuming a log-normal distribution for Δ T S H 3 0 min (33, 35). Some authors (36, 37) have reported that the normal range o f the TSH increment is sex dependent. From the data o f Snyder and Utiger 
(38), and from our own results, i t would appear that the controversial sex dependency w o u l d probably not affect the diagnostic value o f the T R H test as regards the nonstimulation o f TSH levels in thyrotoxicosis and the clearly exag­gerated responses in hypothyroidism. The same applies to possible age dependency (38, 39). Spontaneous bursts o f TSH secretion do not present a problem for the evaluation o f TRH-stimulated TSH levels when compared w i t h other episodically secreted hormones of the anterior pi tui tary . A circadian r h y t h m of TSH secretion was detected only when the sampling intervals were reduced f r o m one hour 
(40) t o 30 minutes (41). Fortunately, the early 
morning peak f r o m 4 a.m. to 6 a.m. does not interfere w i t h normal times for routine endo­crine test procedures. We all know that TSH secretion is increased in primary hypothyroidism. Monitoring o f TSH levels (42, 43) allows a precise assessment o f the daily T 4 requirements in h y p o t h y r o i d patients, w i t h an average dosage o f 172 μg thyroxine per day recently being reported. Monitoring o f the TSH response t o T R H appears to be a still more sensitive parameter for the evaluation o f borderline hypothy­roidism. Thus, the normalization o f basal TSH levels preceded the normalization o f A T S H 3 0 
m j n in a h y p o t h y r o i d patient on t h y r o i d hormone therapy. I n our area (Munich) , we observed in pa­tients w i t h nontoxic goiter an elevated TSH response to T R H in approximately 20 per cent o f the cases (Figure 3 ) . Our interpretation is that these patients may be, first, in a period o f further t h y r o i d growth and, second, borderline h y p o t h y r o i d (35, 44, 45). Monitoring Δ T S H 
3 0 min m goiter patients has been a useful t o o l for determining the dosage of t h y r o i d hormone necessary either for nonsurgical treatment of nontoxic goiter or for postoperative prophy­laxis against recurrence o f the goiter (46). This subject is dealt w i t h in detail by Dr . Medeiros elsewhere in this volume (see p. 4 3 ) . Final ly , I should like to discuss briefly the T R H stimulation test in cases o f t h y r o i d hor­mone excess. With practically no exception, TSH levels are low in thyrotoxicosis and may not be stimulated by T R H . The same pheno­menon was, however, observed in euthyroid Graves' disease (47), as persisting suppression of TSH secretion following treatment for thyro­toxicosis (48), or when treatment w i t h thyro­xine was discontinued (49). In view o f the purposes o f this conference, I now want to draw your attention to the autonomous adenoma of the t h y r o i d . Many patients w i t h autonomous adenomata do not have supranormal levels o f T 4 , as Figure 4 shows. However, all those 14 patients failed to increase their TSH secretion w i t h T R H stimulation. We found an excellent correlation 
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F I G U R E 3. T S H response to standard T R H stimulation and thyroxine iodine in serum 
(CPB-analysis) in cases of nontoxic goiter as compared to normal ranges of control persons 
(35). 
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between negative T R H stimulation tests and 
positive thyrotropin stimulation tests (50). We 
therefore suggested that TSH stimulation tests 
be avoided. Another reason for this recom-
mendation is the potential hazard o f TSH 
stimulation, since it may increase T 4 to a level 
above the upper l imi t o f normal (51). In 
addition, TSH injections are known to give rise 
to the formation of antibodies against bovine 
TSH. 
Figure 5 depicts a scheme for the evolu-
tionary cycle o f the autonomous nodule o f the 
thyroid (50). After the establishment o f auton-
omy in a circumscribed area, thyroid hormone 
levels may rise and Δ T S H 3 0 m i n may fall, 
either subsequently or simultaneously. The 
addition o f thyrotoxic i ty to the autonomy o f a 
nodule is likely to occur when a patient wi th an 
already autonomous nodule is subjected to 
heavy loads o f iodine, e.g. through X-ray 
procedures (52). This, however, is another 
aspect o f the prophylaxis o f endemic goiter, 
which is discussed in more detail elsewhere in 
this volume. 
SUMMARY 
1. Remarkable progress in our under­
standing o f the hypothalamic and pituitary 
control o f the thyroid gland has been achieved 
in recent years. Yet , many questions remain 
unanswered. Some o f these were selected for 
discussion because o f recent renewed interest. 
They include the role of hypothalamic cate­
cholamines; the effect o f cold exposure on the 
hypothalamo-pituitary-thyroid axis; the speci­
fici ty o f the effect o f thyrotropin-releasing 
hormone (TRH) , w i t h emphasis on prolactin 
secretion; and the radioimmunoassay of TRH. 
2. The thyroid-pituitary feedback in the 
absence o f T R H is briefly discussed. Patients 
w i t h hypothalamic disorders illustrate this 
problem. 
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F I G U R E 4 . T S H response to standard T R H stimulation in cases of autonomous adenoma of 
the thyroid (50). A nonsuppressible hot nodule with surrounding thyroid tissue, the latter 
showing suppressed 1 3 1 I -uptake in a subsequent test under exogenous T 3 , is defined as 
kompensiert. The de kompensierte autonomous adenoma represents a hot nodule with 
surrounding thyroid tissue, when the latter is not seen in the first scan but shows 1 3 1 I -uptake 
under stimulation with exogenous T S H (50). 
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F I G U R E 5. Cycle of the autonomous adenoma (50). 
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3. A short review is given o f conditions 
allowing thyroidal growth in the absence of 
TSH. 
4. The introduction o f the radioimmuno­
assay for serum TSH and o f the T R H stimu­
lat ion test has led to major progress in the field 
o f clinical diagnosis o f thyroid disorders. The 
fol lowing problems have been briefly discussed: 
the possible heterogeneity of circulating TSH 
and aspects o f inadequate sensitivity and ac­
curacy of the radioimmunoassay for TSH; the 
normal range for the TSH response to a 
standard T R H stimulation test, and the effects 
of sex and age; the diagnostic implications o f 
supranormal TSH responses to T R H stimulation 
in terms o f preclinical hypothyroidism and 
thyroidal growth; and the diagnostic implica­
tions of suppressed TSH responses to T R H 
stimulation, w i t h special reference to the auton­
omous adenoma o f the t hy ro id . 
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DISCUSSION 
Niepominiszcze: Your last slide reminded me 
o f the study o f McCormack and Sheline ( / 
Nuclear Med 8: 701-708, 1967) in which 14 
patients w i t h autonomous hot nodules were fol-
lowed wi thout any treatment for a period o f 4 
to 8 years. O f these, 11 remained unchanged 
during that period, only 1 became thyrotoxic, 
and 2 had spontaneous remissions. I point this 
out because this study suggests that the major-
i ty o f autonomous hot nodules did not follow a 
specific cycle. 
Scriba: We certainly know that there may 
be spontaneous remissions in cases o f auton-
omous adenomas. On the other hand, I think 
there is no doubt that when autonomous 
adenomas are loaded w i t h iodine, some of them 
may produce severe thyrotoxicosis, for instance 
at the time o f thyroidectomy. I think some of 
the other papers o f this conference w i l l address 
the problem o f the risk o f thyrotoxicosis in 
areas of endemic goiter w i t h autonomous 
nodules, when there is a sudden great increase 
in iodine supplies, such as w i t h the injection o f 
iodized o i l . 
Medeiros-Neto: What are your thoughts on 
the so-called short feedback loop? Would a 
high TSH output block hypothalamic T R H , or 
would i t further stimulate T R H secretion? 
Scriba: I don't know the answer. 1 know of 
two conflicting reports, one o f which says there 
is an increase in T R H excretion in the urine 
during cold exposure and the other that there is 
no T R H in peripheral plasma in a thyro-
dectomized rat. I t seems clear that at present 
we don' t know what the predominant me-
chanism o f regulation is. 
